1. Nivolumab in platinum-refractory head-and-neck cancers: A retrospective observational audit from a tertiary cancer center;Patil;Cancer Res Stat Treat,2022
2. Rajappa SJ, Pinninti R. Real-world evidence with nivolumab in head-and-neck cancer: Access is key! Cancer Res Stat Treat 2022;5:541-3.
3. Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy;Gupta;South Asian J Cancer,2019
4. Low doses in immunotherapy: Are they effective?;Patil;Cancer Res Stat Treat,2019
5. Low-dose immunotherapy in head and neck cancer: A randomized study?;Patil;J Clin Oncol,2022